Oct 04, 2017 | pain management

Pharmacogenomics and Pain: Policy and Ethics

A specialist in public policy and bioethics considers the conundrum of gaining insurance coverage for this cost-efficient but expensive paradigm change to prescribing decisions, as well as some of the ethical issues associated with the practice of pharmacogenomic testing.

Sign Up

Subscribe to the PAINWeek Newsletter
and get our latest articles and more directly in your inbox.